SCHEMBL3014524

SCHEMBL3014524

C/C(=N\Nc1nc2ccccc2s1)c1ccc(-c2cccc(S(=O)(=O)Nc3ncccn3)c2)o1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 1/20 0.68
▸ HSP90AA1 P07900 2/20 0.49
▸ PIK3CA P42336 3/20 0.43
▸ MTOR P42345 3/20 0.43
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ GAA P10253 3/20 0.43
▸ MAPT P10636 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ STAT3 P40763 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.39
▸ AKT1 P31749 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3014526 1.00 BCL2L1 (0.68) BCL2L1HSP90AA1PIK3CAMTORMEN1
SCHEMBL3013124 0.87 BCL2L1 (0.68) BCL2L1HSP90AA1PIK3CAMEN1KMT2A
SCHEMBL3001194 0.83 BCL2L1 (0.89) BCL2L1HSP90AA1MEN1KMT2ARAB9A
SCHEMBL3001197 0.83 BCL2L1 (0.89) BCL2L1HSP90AA1MEN1KMT2ARAB9A
SCHEMBL13209139 0.83 BCL2L1 (0.75) BCL2L1HSP90AA1MEN1KMT2ARAB9A
SCHEMBL3005525 0.82 BCL2L1 (0.94) BCL2L1HSP90AA1MEN1KMT2ARAB9A
SCHEMBL3005522 0.82 BCL2L1 (0.94) BCL2L1HSP90AA1MEN1KMT2ARAB9A
SCHEMBL3654798 0.81 BCL2L1 (0.46) BCL2L1PIK3CAMTORMEN1KMT2A
SCHEMBL3010305 0.79 BCL2L1 (0.65) BCL2L1HSP90AA1MEN1KMT2ARAB9A
SCHEMBL3010309 0.79 BCL2L1 (0.65) BCL2L1HSP90AA1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197711-A1 BENZOTHIAZOLE COMPOUNDS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2010-08-05 — — US disclosed
US-20100197711-A1 BENZOTHIAZOLE COMPOUNDS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2010-08-05 — — US disclosed
EP-2193127-A1 BENZOTHIAZOLE COMPOUNDS The Walter and Eliza Hall Institute of Medical Research (AU) 2010-06-09 — — EP disclosed
WO-2009039553-A1 BENZOTHIAZOLE COMPOUNDS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2009-04-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197711-A1 BENZOTHIAZOLE COMPOUNDS BAD, BCL2, BAX BCL2L1 4/4885HSP90AA1 183/4885PIK3CA 4246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback